Home > Journals > Minerva Urology and Nephrology > Past Issues > Minerva Urology and Nephrology 2021 December;73(6) > Minerva Urology and Nephrology 2021 December;73(6):863-5

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

EDITORIAL COMMENT   Free accessfree

Minerva Urology and Nephrology 2021 December;73(6):863-5

DOI: 10.23736/S2724-6051.21.04814-X

Copyright © 2021 EDIZIONI MINERVA MEDICA

language: English

Prognostic role of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with metastatic castration resistant prostate cancer treated with abiraterone or enzalutamide

Alessandro SCIARRA ✉, Alessandro GENTILUCCI, Susanna CATTARINO, Stefano SALSICCIA, Gianna MARIOTTI

Department of Urology, Sapienza University, Rome, Italy


HTML PDF


top of page

 

Copyright © 2023 Edizioni Minerva Medica

Corporate information        Privacy policy        Terms and conditions